Aevice Health
Aevice Health is a Singapore-based MedTech company dedicated to transforming healthcare through medical innovations that improve outcomes and empower lives. They develop non-invasive wearable devices for remote respiratory monitoring, enabling continuous, real-time detection of cardiopulmonary abnormalities to facilitate early intervention and personalized care at home. Their mission is to improve healthcare accessibility, reduce costs, and provide innovative solutions for chronic respiratory diseases like asthma and COPD.
Industries
Nr. of Employees
small (1-50)
Products
Wearable acoustic respiratory monitoring device
A small, chest-worn acoustic sensor and rechargeable wearable designed to record heart and lung sounds continuously, derive vital signs from acoustics, transmit data to a cloud platform, and support remote auscultation and automated analysis.
Wearable acoustic respiratory monitoring device
A small, chest-worn acoustic sensor and rechargeable wearable designed to record heart and lung sounds continuously, derive vital signs from acoustics, transmit data to a cloud platform, and support remote auscultation and automated analysis.
Services
Cloud-based patient-management service that ingests device-acquired acoustic and vital-sign data, provides longitudinal dashboards, risk stratification, remote auscultation, alerts, and supports telehealth and hospital-at-home workflows.
Cloud-based patient-management service that ingests device-acquired acoustic and vital-sign data, provides longitudinal dashboards, risk stratification, remote auscultation, alerts, and supports telehealth and hospital-at-home workflows.
Expertise Areas
- Remote respiratory monitoring
- Medical acoustic signal analysis
- Machine-learning classification of biosignals
- Clinical validation for respiratory devices
Key Technologies
- Wearable acoustic sensors
- Continuous digital auscultation
- Audio signal processing for lung sounds
- Supervised and multimodal machine learning
News & Updates
In July 2023, Aevice Health announced FDA clearance for its flagship device, AeviceMD, as a Class II medical device, allowing it to market the platform in the US for clinical and home use.
In June 2025, Aevice MD received a patent from the Japan Patent Office, protecting its proprietary respiratory monitoring system and supporting market expansion in Japan.
In August 2024, Aevice Health raised $7 million in funding to expand its remote respiratory monitoring solutions worldwide, with strategic partnerships and product development.
An article highlighting the creation of wearable stethoscopes by NTU graduates, including Aevice Health's innovations.
Aevice Health's AeviceMD was awarded the CES 2023 Best of Innovation Award in digital health category.
Aevice Health received ISO 13485:2016 certification from TÜV SÜD, indicating compliance with international medical device quality standards.
In July 2023, Aevice Health announced FDA clearance for its flagship device, AeviceMD, as a Class II medical device, allowing it to market the platform in the US for clinical and home use.
In June 2025, Aevice MD received a patent from the Japan Patent Office, protecting its proprietary respiratory monitoring system and supporting market expansion in Japan.
In August 2024, Aevice Health raised $7 million in funding to expand its remote respiratory monitoring solutions worldwide, with strategic partnerships and product development.
An article highlighting the creation of wearable stethoscopes by NTU graduates, including Aevice Health's innovations.
Aevice Health's AeviceMD was awarded the CES 2023 Best of Innovation Award in digital health category.
Aevice Health received ISO 13485:2016 certification from TÜV SÜD, indicating compliance with international medical device quality standards.